Published in J Receptor Ligand Channel Res on January 01, 2008
Atp8a1 deficiency is associated with phosphatidylserine externalization in hippocampus and delayed hippocampus-dependent learning. J Neurochem (2011) 1.05
Transport through recycling endosomes requires EHD1 recruitment by a phosphatidylserine translocase. EMBO J (2015) 1.00
P4-ATPases: lipid flippases in cell membranes. Pflugers Arch (2014) 0.97
P4 ATPases: flippases in health and disease. Int J Mol Sci (2013) 0.95
P4-ATPases as Phospholipid Flippases-Structure, Function, and Enigmas. Front Physiol (2016) 0.79
Variation in human cancer cell external phosphatidylserine is regulated by flippase activity and intracellular calcium. Oncotarget (2015) 0.78
flippant-An R package for the automated analysis of fluorescence-based scramblase assays. BMC Bioinformatics (2017) 0.75
Proteomic Analysis of the Rat Canalicular Membrane Reveals Expression of a Complex System of P4-ATPases in Liver. PLoS One (2016) 0.75
Lipid somersaults: Uncovering the mechanisms of protein-mediated lipid flipping. Prog Lipid Res (2016) 0.75
Phospholipid synthesis and lipid composition of subcellular membranes in the unicellular eukaryote Saccharomyces cerevisiae. J Bacteriol (1991) 3.82
Lipid traffic: floppy drives and a superhighway. Nat Rev Mol Cell Biol (2005) 3.28
ATP-dependent asymmetric distribution of spin-labeled phospholipids in the erythrocyte membrane: relation to shape changes. Proc Natl Acad Sci U S A (1984) 3.13
A subfamily of P-type ATPases with aminophospholipid transporting activity. Science (1996) 2.90
Purification and characterization of constitutive secretory vesicles from yeast. J Cell Biol (1987) 2.63
In-depth analysis of the membrane and cytosolic proteome of red blood cells. Blood (2006) 2.44
ATP8B1 requires an accessory protein for endoplasmic reticulum exit and plasma membrane lipid flippase activity. Hepatology (2008) 1.95
Lipid flippases and their biological functions. Cell Mol Life Sci (2006) 1.68
Loss of P4 ATPases Drs2p and Dnf3p disrupts aminophospholipid transport and asymmetry in yeast post-Golgi secretory vesicles. Mol Biol Cell (2006) 1.58
Expression of the yeast plasma membrane [H+]ATPase in secretory vesicles. A new strategy for directed mutagenesis. J Biol Chem (1991) 1.50
Tracking down lipid flippases and their biological functions. J Cell Sci (2004) 1.49
Regulated externalization of phosphatidylserine at the cell surface: implications for apoptosis. J Biol Chem (2007) 1.39
Identification and functional expression of four isoforms of ATPase II, the putative aminophospholipid translocase. Effect of isoform variation on the ATPase activity and phospholipid specificity. J Biol Chem (2000) 1.32
Ion regulation of phosphatidylserine and phosphatidylethanolamine outside-inside translocation in human erythrocytes. Biochim Biophys Acta (1987) 1.25
The type 4 subfamily of P-type ATPases, putative aminophospholipid translocases with a role in human disease. Biochim Biophys Acta (2005) 1.22
Deep coverage mouse red blood cell proteome: a first comparison with the human red blood cell. Mol Cell Proteomics (2008) 1.15
Maintenance of lipid asymmetry in red blood cells and ghosts: effect of divalent cations and serum albumin on the transbilayer distribution of phosphatidylserine. Biochim Biophys Acta (1990) 1.14
The role of phosphatidylserine in recognition and removal of erythrocytes. Cell Mol Biol (Noisy-le-grand) (2004) 1.13
Chemical modification identifies two populations of glycerophospholipid flippase in rat liver ER. Biochemistry (2004) 1.09
A novel aminophospholipid transporter exclusively expressed in spermatozoa is required for membrane lipid asymmetry and normal fertilization. Dev Biol (2004) 1.09
Partial purification and characterization of the human erythrocyte Mg2(+)-ATPase. A candidate aminophospholipid translocase. FEBS Lett (1990) 1.09
Lipid asymmetry of the eukaryotic plasma membrane: functions and related enzymes. Biol Pharm Bull (2006) 1.07
Purification and properties of a vanadate- and N-ethylmaleimide-sensitive ATPase from chromaffin granule membranes. J Biol Chem (1988) 1.06
Multiple erythroid isoforms of human long-chain acyl-CoA synthetases are produced by switch of the fatty acid gate domains. BMC Mol Biol (2006) 1.06
Hydrolysis of phosphatidylserine-exposing red blood cells by secretory phospholipase A2 generates lysophosphatidic acid and results in vascular dysfunction. J Biol Chem (2005) 1.06
Mechanism of ATP-sensitive K channel inhibition by sulfhydryl modification. J Gen Physiol (1998) 1.05
Nitrosative stress inhibits the aminophospholipid translocase resulting in phosphatidylserine externalization and macrophage engulfment: implications for the resolution of inflammation. J Biol Chem (2007) 1.04
Identification of an erythroid ATP-dependent aminophospholipid transporter. Br J Haematol (2006) 0.95
Measurement of outward translocation of phospholipids across human erythrocyte membrane. Proc Natl Acad Sci U S A (1988) 0.94
Aminophospholipid translocation in erythrocytes: evidence for the involvement of a specific transporter and an endofacial protein. Biochemistry (1990) 0.92
ATP-dependent aminophospholipid translocation in erythrocyte vesicles: stoichiometry of transport. Biochemistry (1993) 0.92
Transbilayer movement of phosphatidylserine in erythrocytes. Inhibitors of aminophospholipid transport block the association of photolabeled lipid to its transporter. Biochim Biophys Acta (1991) 0.81
Appearance of voltage-gated calcium channels following overexpression of ATPase II cDNA in neuronal HN2 cells. Brain Res Mol Brain Res (2003) 0.80
Arginine therapy: a new treatment for pulmonary hypertension in sickle cell disease? Am J Respir Crit Care Med (2003) 2.93
VEGF modulates erythropoiesis through regulation of adult hepatic erythropoietin synthesis. Nat Med (2006) 2.67
Mammalian long-chain acyl-CoA synthetases. Exp Biol Med (Maywood) (2008) 2.28
Revised nomenclature for the mammalian long-chain acyl-CoA synthetase gene family. J Lipid Res (2004) 2.08
Decreased arginine bioavailability and increased serum arginase activity in asthma. Am J Respir Crit Care Med (2004) 2.01
Tropomodulin 1-null mice have a mild spherocytic elliptocytosis with appearance of tropomodulin 3 in red blood cells and disruption of the membrane skeleton. Blood (2010) 1.99
Human term placenta as a source of hematopoietic cells. Exp Biol Med (Maywood) (2009) 1.51
Hemolysis-associated pulmonary hypertension in thalassemia. Ann N Y Acad Sci (2005) 1.35
Mammalian acyl-CoA:lysophosphatidylcholine acyltransferase enzymes. Proc Natl Acad Sci U S A (2007) 1.33
Pulmonary hypertension in thalassemia: association with platelet activation and hypercoagulable state. Am J Hematol (2006) 1.31
Erythrocyte glutamine depletion, altered redox environment, and pulmonary hypertension in sickle cell disease. Blood (2007) 1.17
Hydroxyurea and arginine therapy: impact on nitric oxide production in sickle cell disease. J Pediatr Hematol Oncol (2003) 1.14
Imaging of the diffusion of single band 3 molecules on normal and mutant erythrocytes. Blood (2009) 1.12
Activity of the acyl-CoA synthetase ACSL6 isoforms: role of the fatty acid Gate-domains. BMC Biochem (2010) 1.08
Multiple erythroid isoforms of human long-chain acyl-CoA synthetases are produced by switch of the fatty acid gate domains. BMC Mol Biol (2006) 1.06
Hydrolysis of phosphatidylserine-exposing red blood cells by secretory phospholipase A2 generates lysophosphatidic acid and results in vascular dysfunction. J Biol Chem (2005) 1.06
Transfusion prevents acute chest syndrome predicted by elevated secretory phospholipase A2. Br J Haematol (2006) 1.04
Sildenafil therapy in thalassemia patients with Doppler-defined risk of pulmonary hypertension. Haematologica (2013) 0.99
In vivo reduction of erythrocyte oxidant stress in a murine model of beta-thalassemia. Haematologica (2004) 0.98
The effects of disruption of genes for peroxiredoxin-2, glutathione peroxidase-1, and catalase on erythrocyte oxidative metabolism. Free Radic Biol Med (2009) 0.96
Identification of an erythroid ATP-dependent aminophospholipid transporter. Br J Haematol (2006) 0.95
Tapered oral dexamethasone for the acute chest syndrome of sickle cell disease. Br J Haematol (2011) 0.92
Multipotent stromal stem cells from human placenta demonstrate high therapeutic potential. Stem Cells Transl Med (2012) 0.92
Fetal haemoglobin augmentation in E/beta(0) thalassaemia: clinical and haematological outcome. Br J Haematol (2005) 0.92
A 29-kDa protein associated with p67phox expresses both peroxiredoxin and phospholipase A2 activity and enhances superoxide anion production by a cell-free system of NADPH oxidase activity. J Biol Chem (2002) 0.91
Large-scale arrays of picolitre chambers for single-cell analysis of large cell populations. Lab Chip (2010) 0.91
Reactive oxygen species and phosphatidylserine externalization in murine sickle red cells. Br J Haematol (2004) 0.90
A simple assay for frequency of chromosome breaks and loss (micronuclei) by flow cytometry of human reticulocytes. FASEB J (2004) 0.89
Protein kinase C activation induces phosphatidylserine exposure on red blood cells. Biochemistry (2002) 0.89
Selective increase of autoimmune epitope expression on aged erythrocytes in mice: implications in anti-erythrocyte autoimmune responses. J Autoimmun (2002) 0.88
A pilot study of subcutaneous decitabine in β-thalassemia intermedia. Blood (2011) 0.88
Altered red cell turnover in diabetic mice. J Lab Clin Med (2002) 0.88
A randomized, placebo-controlled trial of arginine therapy for the treatment of children with sickle cell disease hospitalized with vaso-occlusive pain episodes. Haematologica (2013) 0.84
Secretory phospholipase A2 levels in patients with sickle cell disease and acute chest syndrome. Hemoglobin (2006) 0.84
Phosphatidylcholine formation by LPCAT1 is regulated by Ca(2+) and the redox status of the cell. BMC Biochem (2012) 0.84
Characterization of an acyl-coenzyme A binding protein predominantly expressed in human primitive progenitor cells. J Lipid Res (2008) 0.84
Inability to maintain GSH pool in G6PD-deficient red cells causes futile AMPK activation and irreversible metabolic disturbance. Antioxid Redox Signal (2015) 0.82
Loss-of-function and gain-of-function phenotypes of stomatocytosis mutant RhAG F65S. Am J Physiol Cell Physiol (2011) 0.81
Measuring chromosome breaks in patients with thalassemia. Ann N Y Acad Sci (2005) 0.81
Eukaryotic protein recruitment into the Chlamydia inclusion: implications for survival and growth. PLoS One (2012) 0.80
Single and combination drug therapy for fetal hemoglobin augmentation in hemoglobin E-beta 0-thalassemia: Considerations for treatment. Ann N Y Acad Sci (2005) 0.80
Remodeling of host phosphatidylcholine by Chlamydia acyltransferase is regulated by acyl-CoA binding protein ACBD6 associated with lipid droplets. Microbiologyopen (2015) 0.80
Postinjury serum secretory phospholipase A2 correlates with hypoxemia and clinical status at 72 hours. J Am Coll Surg (2005) 0.79
Sulphydryl modifications alter scramblase activity in murine sickle cell disease. Br J Haematol (2006) 0.79
Improved engraftment with minimal graft-versus-host disease after major histocompatibility complex-mismatched cord blood transplantation with photochemically treated donor lymphocytes. Exp Biol Med (Maywood) (2011) 0.78
Flow cytometric determination of PMCA-mediated Ca2+-extrusion in individual red blood cells. Cytometry A (2007) 0.78
Serum C-reactive protein parallels secretory phospholipase A2 in sickle cell disease patients with vasoocclusive crisis or acute chest syndrome. Blood (2005) 0.78
Rescued mice with Hb E transgene-developed red cell changes similar to human beta-thalassemia/HbE disease. Ann N Y Acad Sci (2005) 0.78
A transgenic mouse model expressing exclusively human hemoglobin E: indications of a mild oxidative stress. Blood Cells Mol Dis (2012) 0.77
Secretory phospholipase A2: a marker of infection in febrile children presenting to a pediatric ED. Am J Emerg Med (2010) 0.76
Hydroxycarbamide-induced changes in E/beta thalassemia red blood cells. Am J Hematol (2008) 0.76
RBC deformability and amino acid concentrations after hypo-osmotic challenge may reflect chronic cell hydration status in healthy young men. Physiol Rep (2013) 0.75
Research in athletes with sickle cell trait: just do it. J Appl Physiol (1985) (2012) 0.75